参考文献/References:
[1] Sekhon LH, Fehings MG. Epidemiology, demographics, and
pathophysiology of acute spinal cord injury [J]. Spine, 2001,
26(24): 2-12.
[2] Grant RA, Quon JL, Abbed KM. Management of acute trau-
matic spinal cord injury [J]. Curr Treat Options Neurol,
2015, 17(2): 334.
[3] Zhang Y，Wang L，Dey S, et al. Erythropoietin action in
stress response，issue maintenance and metabolism [J]. Int J
Mol Sci, 2014, 15(6): 10296-10333.
[4] 王岩松，姚 猛，刘 斌，等. 脊髓损伤后促红细胞生成素
对bcl-2的影响[J]. 中华显微外科杂志，2006，29（2）：
106-109.
[5] 赵 晔，丁文元，张 为，等. 促红细胞生成素对大鼠急性
脊髓损伤后后肢功能及NF-κB表达的影响[J]. 中国康复
医学杂志，2007，22（10）：904-907.
[6] 孙剑瑞，殷德涛，周金桥. 促红细胞生成素和羊膜间充质
干细胞协同治疗促进脊髓损伤再生[J]. 中华实验外科杂
志，2011，28（7）：1087-1089.
[7] 占乐云，方海滨，吕 恩. 促红细胞生成素和甲基泼尼松
龙对大鼠急性脊髓损伤的疗效比较[J]. 重庆医学，2012，
41（26）：2746-2748.
[8] 杨国宏，张春军，赵富生，等. 自体骨髓基质干细胞移植联
合EPO治疗脊髓损伤的研究[J]. 中国医学创新，2014，11
（32）：1-3.
[9] 谢 中，羊明智，胡文凯，等. EPO联合BMSCs治疗对大
鼠脊髓损伤修复的影响[J]. 中南医学科学杂志，2015，43
（3）：262-265.
[10] 曾智谋，范忠诚，张 寿，等. 骨髓间充质干细胞联合促红
细胞生成素治疗大鼠脊髓损伤[J]. 中华实验外科杂志，
2015，32（4）：854-857.
[11] 王康康，张 辉，方 晓，等. EPO治疗对大鼠脊髓损伤后
脊髓运动功能恢复的实验研究[J]. 安徽医科大学学报，
2016，51（12）：1776-1780.
[12] 郑 竑，张 韬，林振恩，等. 骨髓间充质干细胞靶向移植
和促红细胞生成素联合治疗脊髓损伤[J]. 中华实验外科
杂志，2016，33（11）：2490-2492.
[13] 余化龙，何 宁，刘志刚，等. 骨髓间充质干细胞联合EPO
对急性脊髓损伤大鼠神经功能的影响及机制探讨[J]. 山
东医药，2016，56（18）：37-39.
[14] Vitellaro-Zuccarello, Mazzetti S, Madaschi L, et al. Erythro-
poietin-mediated preservation of the white matter in rat
spinal cord injury [J]. Neuroscience, 2007, 144: 865-877.
[15] Mann C, Lee JH, Liu J, et al. Delayed treatment of spinal
cord injury with erythropoietin or darbepoetin-a lack of
neuroprotective efficacy in a contusion model of cord injury
[J]. Exp Neurol, 2008, 211(1): 34-40.
[16] Fumagalli F, Madaschi L, Brenna P, et al. Single exposure to
erythropoietin modulates nerve growth factor expression in
the spinal cord following traumatic injury: comparison with
methylprednisolone [J]. Eur J Pharmacol, 2008, 578(10):
19-27.
[17] Ning B, Zhang A, Song H, et al. Recombinant human
erythropoietin prevents motor neuron apoptosis in a rat
model of cervical sub-acute spinal cord compression [J].
Neurosci Lett, 2011, 490(1): 57-62.
[18] Zhao Y, Zuo Y, Wang XL, et al. Effect of neural stem cell
transplantation combined with erythropoietin injection on
axon regeneration in adult rats with transected spinal cord
injury [J]. Genet Mol Res, 2015, 14(4): 17799-17808.
[19] Wu MF, Zhang SQ, Gu R, et al. Transplantation of erythro-
poietin gene-modified neural stem cells improves the
repair of injured spinal cord [J]. Neural Regen Res, 2015,
10(9): 1483-1490.
[20] Basso DM, Beattie MS, Bresnahan JC. A sensitive and
reliable locomotor rating scale for open field testing in rats
[J]. J Neurotrauma, 1995, 12(1): 1-21.
[21] Thanka T, Nangaku M. Recent advances and clinical appli-
cation of erythropoietin and erythropoiesis-stimulating
agents [J]. Exp Cell Ress, 2012, 318(9): 1068-1073.
[22] Zhang J, Li Y, Gui Y, et al. Erythropoietin treatment
improves neurological functional recovery in EAE mice [J].
Brain Res, 2005, 1034(1-2): 34-39.
[23] Agnello D, Bigini P, Villa P, et al. Erythropoietin exerts an
anti-inflammatory effect on the CNS in a model of experi-
mental autoimmune encephalomyelitis [J]. brain Res, 2002,
952(1): 128-134.
[24] 朱丽华，施 燕，王诗雨，等. 人重组促红细胞生成素对早
产儿脑室周围白质损伤模型鼠脑血管生成的影响[J]. 中
华实用儿科临床杂志，2015，30（9）：698-701.
[25] Iwai W, Stetler RA, Xing J, et al. Enhanced oligodendroge-
nesis and recovery of neurological function by erythropoietin
after neonatal hypoxic/ischemic brain injury [J]. Stroke,
2010, 41(5): 1032-1037.
[26] Gorio A, Gokmen N, Erbayraktar S, et al. Recombinant
human erythropoietin counteracts secondary injury and
markedly enhances neurological recovery from experimental
spinal cord trauma [J]. Proc Natl Acad Sci U S A，2002, 99
(14): 9450-9455.
[27] Alibai EA, Baqhban F, Farrokhi MR, et al. Effects of human
erythropoietin on functional outcome of patients with trau-
matic cervical cord injury: a pilot randomized clinical trial
[J]. Bull Emerg Trauma, 2015, 3(3): 79-85.
[28] Xiong M, Chen S, Yu H, et al. Neuroprotection of erythropo-
ietin and methylprednisolone against spinal cord ischemia-
reperfusion injury [J]. J Huazhong Univ Sci Technolog Med
Sci, 2011, 31(5): 652-656.
[29] Costa DD, Beqhi E, Cariqnano P, et al. Tolerability and
efficacy of erythropoietin(EPO) treatment in traumatic spinal
cord injury: a preliminary randomized comparative trail vs.
methylprednisolone(MP) [J]. Neurol Sci, 2015, 36(9): 1567-
1574.
[30] 胡 杨，廉 凯，秦 文，等. 促红细胞生成素联合甲泼尼
龙治疗急性脊髓损伤的临床研究[J]. 临床急诊杂志，
2011，12（5）：298-300.
[31] 何玉宝，赵云华，任龙喜，等. 重组人促红细胞生成素联合
甲泼尼龙琥珀酸治疗急性脊髓损伤的临床效果观察[J].
中国综合临床，2017，33(8)：742-747.
相似文献/References:
[1]韩芸峰 综述 王振宇 于 涛 审校.NGF及其受体在脊髓损伤后神经源性肠功能障碍中的研究现状[J].中国临床神经外科杂志,2015,(11):673.[doi:10.13798/j.issn.1009-153X.2015.11.011]
[2]韩芸峰 王振宇 于 涛.大鼠脊髓损伤模型建立及神经源性肠功能障碍的初步评价[J].中国临床神经外科杂志,2015,(10):617.[doi:10.13798/j.issn.1009-153X.2015.10.013]
HAN Yun-feng,WANG Zhen-yu,YU Tao..Establishment of model of spinal cord injury and evaluation of neurogenic bowel disfunction in rats[J].,2015,(07):617.[doi:10.13798/j.issn.1009-153X.2015.10.013]
[3]李国亮 邸 方 杨亚东.香芹酚对大鼠急性脊髓损伤的保护作用[J].中国临床神经外科杂志,2016,(09):549.[doi:10.13798/j.issn.1009-153X.2016.09.012]
LI Guo-liang,DI Fang,YANG Ya-dong..Effects of carvacrol on spinal cord edema and oxidative stress reaction after spinal cord injury in rats[J].,2016,(07):549.[doi:10.13798/j.issn.1009-153X.2016.09.012]
[4]吴 超 于 涛 王振宇 段丽萍.脊髓损伤后神经源性肠功能障碍的发生机制[J].中国临床神经外科杂志,2017,(04):282.[doi:10.13798/j.issn.1009-153X.2017.04.030]
[5]熊 平 唐晓平.促红细胞生成素对大鼠蛛网膜下腔出血后血管痉挛的防治作用[J].中国临床神经外科杂志,2018,(04):254.[doi:10.13798/j.issn.1009-153X.2018.04.010]
XIONG Ping,TANG Xiao-ping..Preventive and therapeutic effects of erythropoietin on cerebral vasospasm after subarachnoid hemorrhage in rats[J].,2018,(07):254.[doi:10.13798/j.issn.1009-153X.2018.04.010]
[6]徐 舒 岳志健 周晓平 王建军 王来兴 张煜辉 刘建民.人脑胶质瘤EPO与CD105表达及意义[J].中国临床神经外科杂志,2018,(05):311.[doi:10.13798/j.issn.1009-153X.2018.05.003]
XU Shu,YUE Zhi-jian,ZHOU Xiao-ping,et al.Expressions of erythropoietin and CD105 in glioma tissues in patients with gliomas and their meanings[J].,2018,(07):311.[doi:10.13798/j.issn.1009-153X.2018.05.003]
[7]刘 明 杭春华 蔡智基 刘美秋 李 松 吴光辉.Necrostatin-1在小鼠脊髓损伤后继发性损伤中的作用[J].中国临床神经外科杂志,2018,(06):419.[doi:10.13798/j.issn.1009-153X.2018.06.012]
LIU Ming,HANG Chun-hua,CAI Zhi-ji,et al.Role of Necrostatin-1 in secondary injury after spinal cord injury in adult mice[J].,2018,(07):419.[doi:10.13798/j.issn.1009-153X.2018.06.012]
[8]刘 芳 刘 莺.EPO联合亚低温治疗新生儿缺氧缺血性脑病的疗效分析[J].中国临床神经外科杂志,2018,(12):795.[doi:10.13798/j.issn.1009-153X.2018.12.010]
LIU Fang,LIU Ying..Effect of erythropoietin combined with hypothermic treatment on neonates with hypoxic-ischemic encephalopathy[J].,2018,(07):795.[doi:10.13798/j.issn.1009-153X.2018.12.010]
[9]陈华辉 王文雄 张刚利 张梦杰 张 豪.促红细胞生成素治疗急性颅脑损伤疗效的meta分析[J].中国临床神经外科杂志,2019,(11):662.[doi:10.13798/j.issn.1009-153X.2019.11.008]
CHEN Hua-hui,WANG Wen-xiong,ZHANG Gang-li,et al.Effect of erythropoietin on acute traumatic brain injury and its safety: a meta-analysis[J].,2019,(07):662.[doi:10.13798/j.issn.1009-153X.2019.11.008]
[10]吴秋萍 邹叶芳 金燕亚.不同方式延续性护理对脊髓损伤病人的效果比较[J].中国临床神经外科杂志,2020,(08):562.[doi:10.13798/j.issn.1009-153X.2020.08.022]
[11]赵雅娜 刘 伟 窦秀云 赵 红 魏 洁 张 莉 李翠花 窦玲云.促红细胞生成素联合甲强龙对脊髓损伤病人神经功能的影响[J].中国临床神经外科杂志,2019,(12):737.[doi:10.13798/j.issn.1009-153X.2019.12.006]
ZHAO Ya-na,LIU Wei,DOU Xiu-yun,et al.Effects of erythropoietin combined with methylprednisolone on neurological function in patients with spinal cord injury[J].,2019,(07):737.[doi:10.13798/j.issn.1009-153X.2019.12.006]